fda guidelines for glp 1 BREAKING NEWS 🚨 Comment “Beyond” my full article with scientific references about why GLP-1s have health benefits beyond weight loss. 🏷️ #semaglutide #glp1 #fda #regulation Wegovy (semaglutide), a glucagon-like peptide-1

However, they arent without risks, some of which may be particularly relevant for women experiencing menopause, including gastrointestinal side effects and bone and muscle loss

doi: 10.1136/gutjnl-2012-304353 75 DickerD

Bojes HK, Datta K, Xu J, Chin A, Simonian P, Nunez G et al

doi: 10.1007/BF00445792 79

Potential Side Effects Common side effects of GLP-1 agonists, particularly during the initial weeks of weight loss treatment, include: Nausea Vomiting Diarrhea Headache Constipation Decreased appetite Pain in the right or middle upper stomach area Fatigue Dizziness Indigestion Injection site reactions (e.g., injection site rash, erythema) Conclusion GLP-1 agonists represent a promising pharmacological approach to weight management, offering significant benefits for individuals struggling with obesity or being overweight

Park, E